Earnings Feed
Start Free
Home/Insiders/KAILIAN VAUGHN M
KV
SEC Insider//CIK 0001180429

KAILIAN VAUGHN M

CIK 000118042914 companiesBOSTON, MA
SEC Profile

Transactions

50

Companies

14

Filings

6

CIK

0001180429

Recent Transactions

50 trades
  • Sale
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2013-03-11$27.86/sh−500,000→ 2,790,479 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Convertible Promissory Note

    2012-02-08−712,567→ 0 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Series A Convertible Preferred Stock

    2012-02-08−1,487,680→ 0 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2012-02-08+1,487,680→ 1,580,660 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2012-02-08+712,567→ 2,293,227 total
  • Purchase
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2012-02-08$7.00/sh+267,857→ 2,561,084 total
  • Purchase
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2012-02-08$7.00/sh+267,857→ 2,828,941 total
  • Purchase
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2011-11-21$6.50/sh+461,538→ 3,290,479 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−15,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−15,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−15,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Award
    CEPHALON INC

    Non-Qualified Stock Option

    2011-05-10+15,000→ 15,000 total
  • Purchase
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2011-02-08$7.00/sh+267,857→ 2,561,084 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Convertible Promissory Note

    2011-02-08−712,567→ 0 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Series A Convertible Preferred Stock

    2011-02-08−1,487,680→ 0 total
  • Purchase
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2011-02-08$7.00/sh+267,857→ 2,828,941 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2011-02-08+1,487,680→ 1,580,660 total
  • Conversion
    Pacira BioSciences, Inc.$PCRX

    Common Stock

    2011-02-08+712,567→ 2,293,227 total
  • Award
    CEPHALON INC

    Non-Qualified Stock Option

    2010-05-20+15,000→ 15,000 total
  • Disposition to Issuer
    PEPLIN INC

    Warrants (right to buy)

    2009-11-11−385,885→ 0 total
  • Disposition to Issuer
    PEPLIN INC

    Common Stock

    2009-11-11−3,419,056→ 0 total
  • Disposition to Issuer
    PEPLIN INC

    Warrants (right to buy)

    2009-11-11−210,937→ 0 total
  • Disposition to Issuer
    PEPLIN INC

    Warrants (right to buy)

    2009-11-11−196,852→ 0 total
  • Award
    CEPHALON INC

    Non-Qualified Stock Option

    2009-05-12+10,000→ 10,000 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-02-12$8.20/sh+1,249→ 3,419,056 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-02-11$8.00/sh+999→ 3,417,807 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-02-09$8.00/sh+999→ 3,416,808 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-02-05$7.80/sh+2,648→ 3,415,809 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-27$8.00/sh+948→ 3,412,431 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-27$8.40/sh+730→ 3,413,161 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-23$8.00/sh+6,029→ 3,411,483 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-22$8.20/sh+1,249→ 3,404,120 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-22$8.00/sh+1,334→ 3,405,454 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-21$8.00/sh+932→ 3,402,871 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-20$8.40/sh+45→ 3,401,939 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-19$8.20/sh+899→ 3,401,894 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-16$8.20/sh+7,340→ 3,400,995 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-15$7.80/sh+1,598→ 3,393,655 total
  • Purchase
    PEPLIN INC

    Common Stock

    2009-01-13$7.03/sh+6,911→ 3,392,057 total
  • Disposition from Tender
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2009-01-01$0.61/sh−14,138,993→ 0 total
  • Sale
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2007-09-14$2.10/sh−27,600→ 14,138,993 total
  • Sale
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2007-09-13$2.12/sh−62,180→ 14,166,593 total
  • Sale
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2007-09-12$2.16/sh−10,000→ 14,228,773 total
  • Other
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2007-06-30+0→ 14,238,773 total
  • Other
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2007-02-28+0→ 14,238,773 total
  • Award
    CEPHALON INC

    Non-Qualified Stock Option (right to buy)

    2005-05-18+15,000→ 15,000 total

Companies

14

Recent Filings

6

Address

C/O MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR

BOSTON, MA, 02116

View on SEC.gov